denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI) , Maternal Health
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI) , Maternal Health
Monday, December 12, 2022: 10:30 AM-12:00 PM
Hall E
(Ernest N. Morial Convention Center)
Moderator:
and
Sarah H. O'Brien, MD, Nationwide Children's Hospital
Disclosures:
O'Brien: Bristol-Myers Squibb-Pfizer Alliance: Other: Dr. O'Brien's institution receives salary support for her role as study chair in a Children's Oncology Group study funded by the BMS-Pfizer Alliance..
Maternal morbidity and mortality closely intersects with hematology. In 2021, ASH indicated that the time is right—given greater awareness, as well as attention to health disparities and their intersection with diversity, equity, and inclusion (DEI)—to explore opportunities for the Society to engage in these important public health issues more fully. The session will cover the current efforts, programs and resources (including but not limited to guidelines), as well as present upcoming plans and opportunities for engagement by hematology community. Additionally, this session will also touch on the current political climate around the right to maternal healthcare and well-being and ways to be an effective advocate. The session will include case studies highlighting ways to bring attention to hematology and maternal health research and practice issues impacted by public policy decisions.
Part I - A Review of ASH Resources
1. Maternal Health in Hematology at ASH
Part II – Ways to be an Effective Advocate
1. Amicus Brief: a Michigan Study
1. Op-ed: a Washington Post Study
1. Grassroots Advocacy: a Tennessee Study
See more of: Special-Interest Sessions